Idioma:

Absence of risk of sarcopenia protects cancer patients from fatigue

Barreto, Cleidiana S ; Borges, Thaís C ; Valentino, Nathalia P ; Gomes, Tatyanne L N ; Soares, Jéssika D P ; Siqueira, Jéssika M ; Pichard, Claude ; Laviano, Alessandro ; Pimentel, Gustavo D

European journal of clinical nutrition, 2022-02, Vol.76 (2), p.206-211 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por

Enviar para

Título:
Absence of risk of sarcopenia protects cancer patients from fatigue
Autor: Barreto, Cleidiana S ; Borges, Thaís C ; Valentino, Nathalia P ; Gomes, Tatyanne L N ; Soares, Jéssika D P ; Siqueira, Jéssika M ; Pichard, Claude ; Laviano, Alessandro ; Pimentel, Gustavo D
Assuntos: Aged ; Alcoholic beverages ; Cancer ; Cancer therapies ; Cross-Sectional Studies ; Fatigue ; Fatigue - etiology ; Fatigue - prevention & control ; Female ; Geriatric Assessment ; Hand Strength ; Health risks ; Humans ; Male ; Neoplasms - complications ; Patients ; Physical activity ; Regression analysis ; Sarcopenia ; Sarcopenia - complications ; Sarcopenia - prevention & control ; Surveys and Questionnaires
É parte de: European journal of clinical nutrition, 2022-02, Vol.76 (2), p.206-211
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: Cancer and its treatments often lead to sarcopenia and fatigue. However, whether these factors are associated remains unproven. To evaluate whether the risk of sarcopenia predicts the presence of fatigue. A cross-sectional study was completed and included 198 cancer patients of both sexes, undergoing in- and outpatient treatment. The Strength, Assistance for walking, Rise from a chair, Climb stairs, and Falls (SARC-F) and the Functional Assessment of Cancer Therapy Fatigue (FACT-F) were used to assess the risk of sarcopenia and the presence of fatigue, respectively. The cut-off values used to identify the risk of sarcopenia and the severity of fatigue scale were SARC-F ≥ 4 and Fatigue <34, respectively. Logistic regression analysis was performed to evaluate the association between SARC-F and the FACT-F. Out of 198 patients, 35% were at risk of sarcopenia and of these 87% had fatigue. Patients at risk of sarcopenia had lower scores in the FACT-F subscales, lower handgrip strength, lower performance status, were mostly hospitalized and were sedentary. Logistic regression analysis revealed that patients with SARC-F < 4 had a lower risk of fatigue in both models, crude (OR: 0.83; CI 95% [0.79-0.88], p < 0.0001) as well as adjusted for age, gender, BMI, physical activity, current use of alcoholic beverages, smoking, performance status, cancer type, clinical setting and use of supplements (OR: 0.87; CI 95% [0.81-0.92], p < 0.0001). In patients with cancer, 35% presented risk of sarcopenia and of these 87% had fatigue. In addition, the absence of sarcopenia was considered protective against fatigue.
Editor: England: Nature Publishing Group
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Absence of risk of sarcopenia protects cancer patients from fatigue

Barreto, Cleidiana S ; Borges, Thaís C ; Valentino, Nathalia P ; Gomes, Tatyanne L N ; Soares, Jéssika D P ; Siqueira, Jéssika M ; Pichard, Claude ; Laviano, Alessandro ; Pimentel, Gustavo D

England: Nature Publishing Group

Buscando em bases de dados remotas. Favor aguardar.